Stuart D. Russell

Active 1999–2025

Also published as
Stuart D Russell
126
Papers
29,118
Citations
85
h-index
123
i10-index

Citations

Citations per year for Stuart D. Russell1964: 1 citations1979: 1 citations1996: 2 citations2001: 1 citations2002: 6 citations2003: 11 citations2004: 16 citations2005: 9 citations2006: 35 citations2007: 43 citations2008: 69 citations2009: 115 citations2010: 208 citations2011: 294 citations2012: 296 citations2013: 371 citations2014: 340 citations2015: 333 citations2016: 277 citations2017: 334 citations2018: 222 citations2019: 817 citations2020: 711 citations2021: 675 citations2022: 545 citations2023: 357 citations2024: 637 citations2025: 296 citations2026: 20 citations1965–1978: no citations, so these years are not shown1980–1995: no citations, so these years are not shown1997–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,964 citing papers, 30.8% of this breakdownUnited Kingdom: 651 citing papers, 6.8% of this breakdownItaly: 609 citing papers, 6.3% of this breakdownGermany: 561 citing papers, 5.9% of this breakdownNetherlands: 454 citing papers, 4.7% of this breakdownCanada: 415 citing papers, 4.3% of this breakdownAustralia: 310 citing papers, 3.2% of this breakdownChina: 294 citing papers, 3.1% of this breakdownFrance: 270 citing papers, 2.8% of this breakdownSpain: 233 citing papers, 2.4% of this breakdownJapan: 233 citing papers, 2.4% of this breakdownSwitzerland: 210 citing papers, 2.2% of this breakdown
0%30.8%Other 25.1%

Fields

  • Medicine69.6%
  • Engineering20%
  • Biochemistry, Genetics and Molecular Biology7.6%
  • Health Professions0.7%
  • Computer Science0.7%
  • Immunology and Microbiology0.3%
  • Other1.1%

Topics

  • Mechanical Circulatory Support Devices8.1%
  • Cardiovascular Function and Risk Factors6.7%
  • Cardiac Structural Anomalies and Repair6.1%
  • Heart Failure Treatment and Management5.5%
  • Cardiovascular Effects of Exercise4.4%
  • Transplantation: Methods and Outcomes4%
  • Other65.2%

Coauthors

All papers

Open in search
  1. Cardiovascular Disease Risk Among Cancer Survivors

    Authors: , , , , , , , , , , , , , - Journal of the American College of Cardiology 2022 cited by 298

  2. Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis

    Authors: , , , , , , , , , , , , , , , , , , , , - JACC Heart Failure 2020 cited by 285

  3. Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial

    Authors: , , , , , , , , , , , , , , , , - Nature Medicine 2021 cited by 199

  4. Exercise Increases Age-Related Penetrance and Arrhythmic Risk in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy–Associated Desmosomal Mutation Carriers

    Authors: , , , , , , , , - Journal of the American College of Cardiology 2013 cited by 695

  5. Prediction of Incident Heart Failure in General Practice

    Authors: , , , , , , , , , , , , , , - Circulation Heart Failure 2012 cited by 267

  6. Guidance for Timely and Appropriate Referral of Patients With Advanced Heart Failure: A Scientific Statement From the American Heart Association

    Authors: , , , , , , , , - Circulation 2021 cited by 188

  7. Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 2009 cited by 3,059

  8. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes

    Authors: , , , , , , , , , , - Journal of Thoracic and Cardiovascular Surgery 2010 cited by 931

  9. Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction

    Authors: , , , , , , - Circulation 2006 cited by 690

  10. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation Cardiovascular Genetics 2015 cited by 481

  11. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: Executive summary

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , J. Eduardo Rame, Stuart D. Russell, Erik N. Sorensen, Benjamin Sun, M. Strueber, Abeel A. Mangi, Michael Petty, Joseph G. Rogers - The Journal of Heart and Lung Transplantation 2013 cited by 1,365

  12. Trends in Hospitalizations and Survival of Acute Decompensated Heart Failure in Four US Communities (2005–2014)

    Authors: , , , , , , , , , - Circulation 2018 cited by 218

  13. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

    Authors: , , , , , , , , , , , , , , - The Lancet 2012 cited by 1,411

  14. Pulmonary Capillary Wedge Pressure Augments Right Ventricular Pulsatile Loading

    Authors: , , , , , , , , , , , - Circulation 2011 cited by 471

  15. Right Ventricular Dysfunction in Systemic Sclerosis–Associated Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , , , , , , , - Circulation Heart Failure 2013 cited by 291

  16. Reduced Kidney Function as a Risk Factor for Incident Heart Failure

    Authors: , , , , , , , - Journal of the American Society of Nephrology 2007 cited by 449

  17. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers

    Authors: , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2015 cited by 428

  18. How Do LLMs Perform Two-Hop Reasoning in Context?

    Authors: , , , , , , - ArXiv.org, CoRR 2025 cited by 17

  19. Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction

    Authors: , , , , , , , , , - JACC Heart Failure 2016 cited by 171

  20. Fatigability, Exercise Intolerance, and Abnormal Skeletal Muscle Energetics in Heart Failure

    Authors: , , , , , , , , , , - Circulation Heart Failure 2017 cited by 145

  21. Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2007 cited by 1,730

  22. Evaluation of the Role of Endomyocardial Biopsy in 851 Patients With Unexplained Heart Failure From 2000–2009

    Authors: , , , , , , , - Circulation Heart Failure 2013 cited by 179

  23. Temporal Trends in Prevalence and Prognostic Implications of Comorbidities Among Patients With Acute Decompensated Heart Failure

    Authors: , , , , , , , , , - Circulation 2020 cited by 103

  24. Improved outcomes in peripartum cardiomyopathy with contemporary

    Authors: , , - American Heart Journal 2006 cited by 326